Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Granuloma

moxifloxacin has been researched along with Granuloma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Agarwal, M; Dhawan, A; Gupta, C; Jha, V; Mohan, KV; Upadhyay, PK1
Arrey, F; Gengenbacher, M; Kaiser, P; Kaufmann, SHE; Krishnamoorthy, G; Kuhlmann, S; Löwe, D; Lozza, L; Maertzdorf, J; Moura-Alves, P; Nouailles, G; Skrahina, A; Skrahina, T1
Barry, CE; Dartois, V; Goh, A; Kern, S; Kjellsson, MC; Low, KM; Pillai, G; Via, LE; Weiner, D1
Bishai, WR; Davis, SL; Harper, J; Jain, SK; Kramnik, I; Nuermberger, EL; Pomper, MG; Skerry, C; Tasneen, R; Weir, M1
Botzenhart, K; Dalhoff, A; Döring, G; Kaygin, H; Steinhuber, A; Worlitzsch, D1

Other Studies

5 other study(ies) available for moxifloxacin and Granuloma

ArticleYear
Adjunctive Intravitreal Anti-vascular Endothelial Growth Factor and Moxifloxacin Therapy in Management of Intraocular Tubercular Granulomas.
    Ocular immunology and inflammation, 2023, Volume: 31, Issue:1

    Topics: Angiogenesis Inhibitors; Bevacizumab; Fluorescein Angiography; Granuloma; Humans; Intravitreal Injections; Moxifloxacin; Ranibizumab; Tomography, Optical Coherence; Tuberculosis, Ocular; Vascular Endothelial Growth Factor A

2023
Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for
    Frontiers in immunology, 2019, Volume: 10

    Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Granuloma; Hematopoietic Stem Cell Transplantation; Humans; Lung; Male; Mice; Mice, Inbred C57BL; Moxifloxacin; Mycobacterium tuberculosis; Tuberculosis, Pulmonary

2019
Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Animals; Antitubercular Agents; Aza Compounds; Biological Availability; Disease Models, Animal; Drug Administration Schedule; Female; Fluoroquinolones; Granuloma; Humans; Isoniazid; Lung; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Rabbits; Rifampin; Tissue Extracts; Tuberculosis, Pulmonary

2012
Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions.
    The Journal of infectious diseases, 2012, Feb-15, Volume: 205, Issue:4

    Topics: Animals; Antitubercular Agents; Aza Compounds; Disease Models, Animal; Fluoroquinolones; Gene Expression Profiling; Genes, Bacterial; Granuloma; Hypoxia; Immunohistochemistry; Male; Mice; Mice, Inbred C3H; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Positron-Emission Tomography; Pyrazinamide; Quinolines; Treatment Outcome; Tuberculosis

2012
Effects of amoxicillin, gentamicin, and moxifloxacin on the hemolytic activity of Staphylococcus aureus in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:1

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Blotting, Northern; Blotting, Western; Coloring Agents; Congo Red; Cystic Fibrosis; Fluoroquinolones; Gentamicins; Granuloma; Hemolysis; HLA Antigens; Humans; Leukocyte Elastase; Male; Moxifloxacin; Penicillins; Quinolines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcal Protein A; Staphylococcus aureus

2001